3Daughters Announces Appointment of John Poulos to the Board of Directors
Poulos, former Head of Business Development at AbbVie, brings significant operational experience to support the Company's growth strategy in women’s...
Pharmaceutical
Chicago Biomedical Consortium to Serve as Regional Host Committee Chair for BioCentury’s Grand Rounds – U.S. Conference
Chicago to host 2025 Grand Rounds ConferenceCHICAGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The Chicago Biomedical Consortium (“CBC”), a Midwest center...
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery...
IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients
100% of acute myeloid leukemia (AML) patients across both original and expansion cohorts remain in complete remission (CR), with a...
Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025
MONTREAL and CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on...
Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia
No serious side effects or discomfort observed Final safety and absorption data expected in March 2025 SARASOTA, FL, Feb. 11,...
Firefly Neuroscience Accepted into NVIDIA Connect Program
Collaboration to provide Firefly with the technical resources to help further unleash the power of its FDA-cleared BNA™ platform For...
Cytokinetics Names Robert E. Landry to Board of Directors
Appointment Deepens Financial and Operational Expertise of Boardas Company Approaches Potential Commercialization SOUTH SAN FRANCISCO, Calif., Feb. 11, 2025 (GLOBE...
Repligen to Report Fourth Quarter and Full Year 2024 Financial Results
Webcast and Conference Call to Be Held Thursday, February 20, 2025, at 8:30 a.m. ETWALTHAM, Mass., Feb. 11, 2025 (GLOBE...
Frontier Scientific Solutions Announces Full-Scale Construction of Largest GMP Temperature-Controlled Facility for Life Sciences in North America at Wilmington International Airport
WILMINGTON, N.C., Feb. 11, 2025 /PRNewswire/ -- Frontier Scientific Solutions is excited to announce that construction of its state-of-the-art cGMP...
Cosmo Appoints Andrea Cherubini as Chief AI Officer to Drive AI Expansion Across Portfolio
Dublin, Ireland--(Newsfile Corp. - February 11, 2025) - Planet Friendly Technologies, Inc.Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today...
Palatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025
CRANBURY, N.J., Feb. 10, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter fiscal year...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2025 Financial Results on February 14, 2025
Financials for the Third Quarter of Fiscal Year 2025 Ended December 31, 2024 will be released on Thursday, February 13,...
SandboxAQ Expands Alliance with Deloitte to Offer AI Simulation Software Solutions
Alliance to add focus for Large Quantitative Models (LQMs) which are the new frontier in AI with applications in biopharma,...
ETQ Reaches Significant Milestones in Final Quarter of 2024, Reinforces its Leadership in Advanced Quality Management Systems for Manufacturers
Key Milestones Include Launch of ETQ Reliance Predictive Analytics Solution, Expanding Client Base, Annual Customer Conference and Innovation Awards BURLINGTON,...
GE HealthCare management to present at upcoming investor conference
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at Citi’s 2025 Medtech and...
GE HealthCare management to present at upcoming investor conference
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at Citi’s 2025 Medtech and...
Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
Data presented at the 2025 Crohn’s and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model...
BioCryst to Present New ORLADEYO® (berotralstat) Results from APeX-P Pediatric Trial at 2025 American Academy of Allergy, Asthma & Immunology / World Allergy Organization Joint Congress
RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will...
Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial
No Safety Concerns Identified by DSMC in the ORCA-OL Long-Term Exposure Trial Achieve Reiterates Planned Cytisinicline NDA Submission in Q2...